Better Buy: Abbott Laboratories vs. Novo Nordisk
Lots of companies market products that help individuals manage diabetes. Abbott Laboratories (NYSE: ABT) and Novo Nordisk (NYSE: NVO) rank as two of the biggest of these companies in the diabetes arena. But neither Abbott nor Novo Nordisk focuses exclusively on diabetes.
Both stocks have underperformed the S&P 500 index so far this year. However, both stocks also have solid growth opportunities. Which is the better pick for long-term investors? Here's how Abbott and Novo Nordisk stack up against each other.
Image source: Getty Images.
Source Fool.com
